ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ChiCTR
Last refreshed on:	18 April 2017
Main ID:	ChiCTR-ONC-16009445
Date of registration:	2016-10-16
Prospective Registration:	Yes
Primary sponsor:	Shanghai Tenth People's Hospital
Public title:	Study on the MDT standard and model of the HIFU treatment for pancreatic cancer
Scientific title:	Study on the MDT standard and model of the HIFU treatment for pancreatic cancer
Date of first enrolment:	2016-12-01
Target sample size:	HIFU treatment group:120;
Recruitment status:	Pending
URL:	http://www.chictr.org.cn/showproj.aspx?proj=16156
Study type:	Observational study
Study design:	Case series
Phase:	New Treatment Measure Clinical Study

Countries of recruitment
China

Contacts

Name:	Zhu Zhongzheng
Address:	301 Middle Yanchang Road, Shanghai
Telephone:	+86 13817057105
Email:	zzzhu1170@yeah.net
Affiliation:	Shanghai Tenth People's Hospital

Name:	Zhu Zhongzheng
Address:	301 Middle Yanchang Road, Shanghai
Telephone:	+86 13817057105
Email:	zzzhu1170@yeah.net
Affiliation:	Shanghai Tenth People's Hospital

Key inclusion & exclusion criteria

Inclusion criteria: (1) Pancreas cancer who can not tolerate surgery;
(2) tumor can not be removed by surgery;
(3) the expected survival of more than 3 months;
(4) the lesion(s) can be clearly shown in the airborne ultrasound;
(5) no obvious obstructive jaundice;
(6) enough sound channel;
(7) signed informed consent
Exclusion criteria: (1) Refuse to sign the informed consent;
(2) ultrasound visualization of the lesion is not clear;
(3) there are medical implantsin sound channel of HIFU treatment;
(4) uncorrectable obstructive jaundice;
(5)pancreatic cancer had received more than 45Gy radiotherapy.

Age minimum: 18
Age maximum: 80
Gender: Both

Health Condition(s) or Problem(s) studied

Pancreas Cancer

Intervention(s)

HIFU treatment group:HIFU treatment under MDT mode ;

Primary Outcome(s)

Tumor size and inactivation;tumor marker level;clinical benefit rate;score of life quality;

Secondary Outcome(s)

Secondary ID(s)

Source(s) of Monetary Support

Shanghai Shenkang Hospital Development Center

Secondary Sponsor(s)

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.